Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel-Reference-Cited by-同舟云学术

Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel

Published:2015-04-10 Issue:4 Volume:10 Page:e0119681
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Stilund Morten,Gjelstrup Mikkel Carstensen,Petersen Thor,Møller Holger Jon,Rasmussen Peter Vestergaard,Christensen Tove

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference73 articles.

1. Multiple sclerosis;A Compston;Lancet,2002

2. Multiple sclerosis;A Compston;Lancet,2008

3. Pathology of multiple sclerosis;M Kipp;CNS Neurol Disord Drug Targets,2012

4. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis;D Miller;Lancet neurology,2005

5. Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry;CE Teunissen;Multiple sclerosis,2011

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From progression to progress: The future of multiple sclerosis;Journal of Central Nervous System Disease;2024-05-06

2. Blood-brain barrier biomarkers;Advances in Clinical Chemistry;2024

3. Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysis;2023-12-07

4. Plasma IgG aggregates as biomarkers for multiple sclerosis;Clinical Immunology;2023-11

5. Clinical Utility of Soluble CD163 and its Diagnostic and Prognostic Value in a Variety of Neurological Disorders;Mini-Reviews in Medicinal Chemistry;2023-09